CoverageForm 410-K10-Q8-K13D13G13F

ATR · Aptargroup, Inc. - Financials

Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.

Price · ATR

Income Statement

Line itemQ1 '26Q4 '25Q3 '25Q2 '25Q1 '25Q4 '24Q3 '24Q2 '24Q1 '24Q4 '23
Revenue$982.87M-$961.13M$966.01M$887.30M-$909.29M$910.06M$915.45M-
Cost of Revenue----------
Gross Profit----------
R&D----------
SG&A----------
Total Operating Expenses$875.37M-$824.21M$821.62M$773.86M-$770.99M$784.05M$803.37M-
D&A$75.72M---$65.65M-$67.02M$64.97M$64.35M-
Operating Income$107.50M-$136.92M$144.39M$113.45M-$138.30M$126.01M$112.08M-
Interest Expense$16.94M-$13.53M$10.85M$10.18M-$12.29M$10.06M$10.18M-
Income Tax$21.00M-$26.30M$27.98M$27.35M-$31.21M$27.79M$21.39M-
Net Income$72.67M-$127.93M$111.72M$78.80M-$100.04M$90.45M$83.10M-
EPS - Basic$1.13-$1.95$1.69$1.19-$1.51$1.36$1.26-
EPS - Diluted$1.12-$1.92$1.67$1.17-$1.48$1.34$1.23-

Balance Sheet

Line itemQ1 '26Q4 '25Q3 '25Q2 '25Q1 '25Q4 '24Q3 '24Q2 '24Q1 '24Q4 '23
Cash & Equivalents$222.53M$402.42M$257.06M$161.73M$125.84M$223.84M$325.52M$221.49M$199.83M$223.64M
Accounts Receivable-----$658.10M---$677.80M
Inventory$551.48M$537.85M$547.30M$527.42M$483.52M$461.81M$488.54M$484.61M$496.84M$513.05M
Accounts Payable-$340.56M---$295.97M---$328.57M
Current Assets$1.77B$1.89B$1.78B$1.66B$1.51B$1.48B$1.67B$1.59B$1.56B$1.55B
Total Assets$5.10B$5.25B$5.10B$4.87B$4.53B$4.43B$4.63B$4.45B$4.44B$4.45B
Current Liabilities$1.06B$1.17B$1.50B$1.37B$1.21B$1.07B$1.03B$1.17B$1.20B$1.25B
Long-term Debt----------
Total Liabilities----------
Stockholders' Equity$2.63B$2.67B$2.77B$2.70B$2.54B$2.47B$2.54B$2.40B$2.35B$2.31B
Retained Earnings$2.68B$2.64B$2.60B$2.50B$2.42B$2.37B$2.30B$2.23B$2.17B$2.11B

Cash Flow

Line itemQ1 '26Q4 '25Q3 '25Q2 '25Q1 '25Q4 '24Q3 '24Q2 '24Q1 '24Q4 '23
Operating Cash Flow$118.69M---$82.74M---$92.33M-
Investing Cash Flow($65.10M)---($56.63M)---($76.57M)-
Financing Cash Flow($230.34M)---($134.78M)---($35.75M)-
CapEx$65.40M---$56.86M---$75.66M-
Free Cash Flow$53.30M---$25.88M---$16.67M-

Ratios

MetricQ1 '26Q4 '25Q3 '25Q2 '25Q1 '25Q4 '24Q3 '24Q2 '24Q1 '24Q4 '23
Profitability
Gross margin----------
Operating margin10.9%-14.2%14.9%12.8%-15.2%13.8%12.2%-
EBITDA margin18.6%---20.2%-22.6%21.0%19.3%-
Net margin7.4%-13.3%11.6%8.9%-11.0%9.9%9.1%-
Free cash flow margin5.4%---2.9%---1.8%-
FCF / Net income0.73---0.33---0.20-
R&D / Revenue----------
SG&A / Revenue----------
Effective tax rate22.4%-17.1%20.0%25.8%-23.8%23.5%20.5%-
Return on assets1.4%-2.5%2.3%1.7%-2.2%2.0%1.9%-
Return on equity2.8%-4.6%4.1%3.1%-3.9%3.8%3.5%-
Return on invested capital----------
Liquidity
Current ratio1.661.621.191.211.251.381.621.361.301.24
Quick ratio1.141.160.820.830.850.951.150.950.890.83
Cash ratio0.210.350.170.120.100.210.320.190.170.18
Leverage
Debt / Equity----------
Debt / Assets----------
Debt / EBITDA----------
Interest coverage6.3x-10.1x13.3x11.1x-11.3x12.5x11.0x-
Equity multiplier1.941.971.841.801.781.791.821.861.891.93
Liabilities / Assets----------
Efficiency
Asset turnover0.19-0.190.200.20-0.200.200.21-
Inventory turnover----------
Days sales outstanding----------
Days inventory outstanding----------
Days payable outstanding----------
Cash conversion cycle----------
Valuation
P / E112.5x-69.6x93.7x126.8x-108.2x105.1x117.0x-
P / B3.1x-3.2x3.9x3.9x-4.3x4.0x4.1x-
P / S8.3x-9.3x10.9x11.3x-11.9x10.5x10.6x-
EV / EBITDA43.4x---55.2x-51.2x48.7x53.9x-
Growth
Revenue growth (YoY)10.8%-5.7%6.1%-3.1%-1.8%1.6%6.4%-
Revenue CAGR (3y)4.5%-4.7%4.6%1.6%-3.3%3.9%5.6%-
Revenue CAGR (5y)4.8%-4.8%6.7%4.2%-5.3%4.1%4.2%-
Gross profit growth (YoY)----------
Operating income growth (YoY)-5.2%--1.0%14.6%1.2%-15.9%8.1%33.5%-
Net income growth (YoY)-7.8%-27.9%23.5%-5.2%-18.7%8.9%51.7%-
EPS growth (YoY)-4.3%-29.7%24.6%-4.9%-17.5%8.1%50.0%-
EPS CAGR (3y)11.0%-33.3%20.7%8.0%-28.3%18.3%-0.3%-
EPS CAGR (5y)-2.0%-15.1%21.5%6.9%-11.7%3.7%5.1%-
FCF growth (YoY)105.9%---55.2%----18.6%-
FCF CAGR (5y)45.0%---2.0%----8.4%-
Book value growth (YoY)3.6%7.9%9.1%12.7%8.0%7.2%15.4%10.2%11.2%12.3%

Sales by segment

From XBRL dimensional facts in the 10-K period ending 2025-12-31.

Business segments

$3.81B total
Pharma Segment$1.74B · 45.6%
Beauty Segment$1.34B · 35.1%
Closures Segment$736.94M · 19.3%

Geographic

$5.64B total
Europe$1.86B · 33.0%
US$1.07B · 19.0%
Other Europe$788.07M · 14.0%
Other Foreign Countries$648.79M · 11.5%
FR$513.28M · 9.1%
IT$201.90M · 3.6%
ES$195.41M · 3.5%
CN$194.41M · 3.4%
DE$163.91M · 2.9%

Peer comparison

Same SIC group: Plastics Products, NEC

CompanyRevenue (last FY)Net marginROE
ENTG$3.20B7.4%6.0%
AZEK---
NWL$7.20B-4.0%-11.9%
CMT$273.80M4.1%7.1%
SWIM$545.91M2.0%2.7%

Comparing APTARGROUP against the 5 most active filers in the same SIC group.

Dividends

$1.89/share trailing 12 months · +5.0% YoY

Ex-datePer share
May 6, 2026$0.4800
Feb 4, 2026$0.4800
Oct 23, 2025$0.4800
Jul 24, 2025$0.4500
May 1, 2025$0.4500
Feb 5, 2025$0.4500
Oct 24, 2024$0.4500
Jul 25, 2024$0.4500
Apr 24, 2024$0.4100
Jan 31, 2024$0.4100
Oct 25, 2023$0.4100
Jul 26, 2023$0.4100
May 3, 2023$0.3800
Feb 1, 2023$0.3800
Oct 25, 2022$0.3800
Jul 26, 2022$0.3800
Apr 26, 2022$0.3800
Feb 2, 2022$0.3800
Oct 26, 2021$0.3800
Aug 3, 2021$0.3800
Apr 27, 2021$0.3800
Jan 26, 2021$0.3600
Oct 27, 2020$0.3600
Jul 28, 2020$0.3600